Noah Berkowitz, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Noah Berkowitz, M.D., Ph.D.
Arvinas, Inc. reported in an 8-K filed March 18, 2024 that Noah Berkowitz, M.D., Ph.D. was appointed chief medical officer, effective March 18, 2024. Noah Berkowitz, M.D., Ph.D. has spoken on 1 earnings call across 1 company, most recently for Arvinas, Inc. on May 12, 2026.
“On March 18, 2024, Arvinas, Inc., a Delaware corporation (the "Company"), announced the appointment of Noah Berkowitz, M.D., Ph.D., to the role of chief medical officer, effective as of March 18, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Arvinas, Inc. (ARVN)
SEC 8-K
Current2024-03-18–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arvinas, Inc.
Other people whose current roles at this company are on record from its filings.
- Randy Teel, Ph.D. CEO, Board Member
- Briggs Morrison, M.D. Chairman
- Randy Teel CFO
- David Loomis Chief Accounting Officer
- Everett Cunningham Board Member
- John Houston Board Member
- John Young Board Member
- Laurie Smaldone Alsup Board Member
- Linda Bain Board Member
- Wendy Dixon, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.